The Spark #2: Alpha-Synuclein clumps visualized, MRgFUS, and New Ways to Track Stress
New ways to understand Parkinson’s are emerging. Scientists finally saw the tiny protein clumps behind the disease, while other studies point to benefits from caffeine, less toxin exposure, and tracking stress. Plus some interesting data on neuromodulation.
The brief
Fresh sparks from the world of Parkinson’s:
- For the first time, scientists have visualized tiny clumps of alpha-synuclein in human brain tissue. Using a new imaging method, they found these early aggregates even in small amounts in healthy brains, suggesting they may form naturally but turn harmful in Parkinson’s. Spotting these early protein changes gives researchers a clearer view of when and where Parkinson’s may begin, not just where it causes damage. It opens new possibilities for earlier detection and targeted therapies.
- A phase 3 trial of a staged, bilateral MRI‑guided focused ultrasound (MRgFUS) procedure, specifically targeting the pallidothalamic tract in patients with Parkinson’s disease (PD) who were experiencing motor complications, showed meaningful benefit. Patients first had unilateral treatment (improvement ~50 % on the MDS-UPDRS Part III OFF score) then many proceeded to the bilateral stage (improvement ~33.9 %). This could provide a less-invasive alternative to deeper surgical options, especially for bilateral symptoms.
- A new randomized clinical trial found that a wearable neuromodulation device significantly improved tremor-related daily activities in people with Essential tremor. After 90 days, those using the device improved by about 6.9 points on a daily living scale, versus 2.7 points for the control group. This non-invasive technology could become a valuable new option for tremor management.
- Most Parkinson’s cases aren’t genetic (as far as we know) and new research suggests prevention is possible. Regular caffeine intake (2–3 cups of coffee or tea a day) is linked to a 25–30% lower risk, while exposure to industrial solvents, pesticides, or contaminated water may raise it. Experts say limiting chemical exposure and keeping up healthy habits like moderate caffeine use could meaningfully cut Parkinson’s risk. As this article in The Washington Post suggests.
Paper Under Review
Stressomic: A wearable microfluidic biosensor for dynamic profiling of multiple stress hormones in sweat
Stress often worsens Parkinson’s symptoms, but it’s been hard to measure. A new study introduces a wearable sensor that tracks stress hormones like cortisol and adrenaline in real time through sweat. While not tested in Parkinson’s yet, it could help explain how stress spikes relate to symptom flares, and eventually guide more personalized care.
The Human Spark
A major viral story features Denise Bacon, a 65-year-old patient who played her clarinet during a four-hour deep brain stimulation surgery at King’s College Hospital in London. Remaining awake throughout the operation, Bacon experienced instant improvement in finger dexterity, demonstrating the precision and immediacy of DBS effects on motor function.
Spark tip
People with Parkinson’s often have lower Vitamin D levels, which are linked to more severe motor symptoms. Some research suggests that supplementing Vitamin D might modestly improve movement and walking ability, though the effects are mild. Importantly, Vitamin D doesn’t seem to interfere with Levodopa. Its absorption or side effects remain unchanged. Still, it’s something worth discussing with your doctor.
Don't forget to share
Over 10 million people live with Parkinson’s, and the number is quickly growing. Help by sharing The Spark with someone who’d love a dose of hope and science.
Disclaimer: SparkPD is for informational purposes only and not medical advice.